PL EN


Preferencje help
Widoczny [Schowaj] Abstrakt
Liczba wyników
2017 | z. 81, nr 2 | 125--136
Tytuł artykułu

A Comparison of Two Enzymatic Methods of Clinical Dextran Production

Treść / Zawartość
Warianty tytułu
Języki publikacji
EN
Abstrakty
EN
The aim of this study was to evaluate and compare of the two enzymatic methods of clinical dextran production were compared. The reactions were performed at 30°C and pH 5.4 in solutions containing different amounts of sucrose, using dextransucrase (DS, in the presence of dextranase (D) (method 1) or acceptor dextrans (method 2). The activity of Leuconostoc mesenteroides L dextransucrase (DS), which converts sucrose to dextran, was 0.4 U ml-1 in both the methods. As much as 53-56% of clinical dextran fractions were obtained for 28 h from 10% sucrose solutions, which contained 1.5% or 2.5% acceptor dextrans with molecular mass of 10 and 15 kDa, respectively. Approximately 50% of these fractions was obtained (also in 28 h) from 10% sucrose solutions by using 0.004 U ml-1 of DN, added to reaction mixtures 5 h later than Our experiments indicate that the clinical dextran can be efficiently produced by using both the compared methods, which employ either acceptor dextrans with definite molecular mass, or the dextranase. Because consumption of the latter enzyme is rather small, and it is easily available, thus this method should be attractive for clinical dextran manufacturers. (original abstract)
Rocznik
Numer
Strony
125--136
Opis fizyczny
Twórcy
  • Lodz University of Technology, Poland
autor
  • Lodz University of Technology, Poland
  • Lodz University of Technology, Poland
Bibliografia
  • Robyt JF. Dextran. In. Encyclopedia of Polymer Science and Engineering. Mark HF, Bikales NM, Overberger CG., Menges G, Eds.; John Wiley &Sons, New York, USA, 1986, 752-767.
  • Alsop RM. Industrial production of dextrans. Prog Ind Microbiol 1983, 18:1-44.
  • Tsuchiya HM, Hellman NN, Koepsell HJ. Factors affecting molecular weight of enzymatically synthesized dextran. J Am Chem Soc 1955, 77:2412-2419.
  • Paul F, Oriol E, Auriol D, Monsan P. Acceptor reaction of a highly purified dextransucrase with maltose and oligosaccharides. Application to the synthesis of controlled-molecular-weight dextrans. Carbohyd Res 1986, 149:433-441.
  • Remaud M, Paul F, Monsan P, Heyraud A, Rinaudo M. Molecular weight characterization and structural properties of controlled molecular weight dextrans synthesized by acceptor reaction using highly purified dextransucrase. J Carbohyd Chem 1991, 10:861-876.
  • Novak LJ, Witt EE. Method of producing clinical dextran. US Patent 1961, 2972567.
  • Kim D, Day DF. Isolation of a dextranase constitutive mutant of Lipomyces starkeyi and its use for the production of clinical size dextran. Lett Appl Microbiol 1995, 20:268-270.
  • Kim D, Day DF. A new process for the production of clinical dextran by mixed-culture fermentation of Lipomyces starkeyi and Leuconostoc mesenteroides. Enzyme Microb Technol 1994, 16:844-848.
  • Kim D, Hyun-Chang S, Day DF. Dextran production by Leuconostoc mesenteroides dextransucrase in the presence of a dextranase producing yeast, Lipomyces starkeyi. Biotechnol Tech 1996, 10(4):227-232.
  • Moulis C, Vaca Medina G, Suwannarangsee S, Monsan P, Remaud0Simeon M, Potocki-Veronese G. One step synthesis of isomalto-oligosaccharide syrups and dextrans of controlled size using engineered dextransucrase. Biocatalysis and Biotransformation 2008, 26:141-151.
  • Chen S, Liu L, Lu J, Han Z, Xu Y, Mo H. Clinical dextran purified by electric ultrafiltration coupling with solvent crystalization. C.R.Chimie 2008, 11:80-83.
  • Miller GL. Use of dinitrosalicylic acid reagent for determination of reducing sugar. Anal Chem 1959, 31:426-428.
  • Somogyi M. Notes on sugar determination. J Biol Chem 1952, 195:19-23.
  • Nelson N. Arsenomolybdate method of sugar determination. In: Methods in Enzymology. Colovick SP, Kaplan NO, Eds.; Acad. Press New York, USA, 1957, 85-86.
  • Wolff IA, Mehltretter CL, Mellies RL, Watson PR, Hofreiter BT, Patric PL, Rist CE. Production of clinical type dextran. Partial hydrolityc depolymerization and fractionation of the dextran from Leuconostoc mesenteroides strain NRRL B-512. Ind Eng Chem 1954, 46:370-374.
  • Khalikova E, Susi P, Korpela T. Microbial dextran - hydrolyzing enzyme: Fundamentals and applications. Microbiol Mol Biol Rev 2005, 69:306-325
  • Robyt JF, Walseth TF. The mechanism of acceptor reactions of Leuconostoc mesenteroides B-512F dextransucrase. Carbohydr Res 1978, 61:433-445.
  • Lee S, Choi S, Kim E, Koo Y. Continuous production of clinical dextran using two-stage reactor. Biotechnol Lett 1992, 14:379-384.
Typ dokumentu
Bibliografia
Identyfikatory
Identyfikator YADDA
bwmeta1.element.ekon-element-000171578560

Zgłoszenie zostało wysłane

Zgłoszenie zostało wysłane

Musisz być zalogowany aby pisać komentarze.
JavaScript jest wyłączony w Twojej przeglądarce internetowej. Włącz go, a następnie odśwież stronę, aby móc w pełni z niej korzystać.